omniture
logo
Search
百奥赛图（北京）医药科技股份有限公司 Biosetu (Beijing) Pharmaceutical Technology Co. Ltd
Media Room

Photo News

rss
Biocytogen/Eucure Biopharma to Present Clinical Data from YH003 (anti-CD40 mAb) and YH001 (anti-CTLA-4 mAb) Trials at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Biocytogen/Eucure Biopharma to Present Clinical Data from YH003 (anti-CD40 mAb) and YH001 (anti-CTLA-4 mAb) Trials at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

2022-05-24 08:00 2089
Biocytogen Enters into Antibody Agreement with Merck

Biocytogen Enters into Antibody Agreement with Merck

2022-04-29 20:00 2517
Biocytogen Signs RenMab™/RenLite™ Licensing Agreement with BeiGene

Biocytogen Signs RenMab™/RenLite™ Licensing Agreement with BeiGene

2022-04-08 21:00 5261
Biocytogen Expands Global Footprint with the Opening of Biocytogen Europe Innovation Center in Germany

Biocytogen Expands Global Footprint with the Opening of Biocytogen Europe Innovation Center in Germany

2022-03-28 21:30 1800